Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 5:01 pm Sale | 13G | INTERPACE BIOSCIENCES INC IDXG | Singer Douglas Mark | 250,000 5.78% | -105,165 (-29.61%) | View |
| 2023-02-10 4:23 pm Purchase | 13G | INTERPACE BIOSCIENCES INC IDXG | Singer Douglas Mark | 355,165 8.32% | 62,165 (+21.22%) | View |
| 2022-02-10 5:14 pm Purchase | 13G | INTERPACE BIOSCIENCES INC IDXG | Singer Douglas Mark | 293,000 6.98% | 293,000 (New Position) | View |
| 2022-02-01 10:15 am Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Kamin Peter | 781,956 18.6% | 0 (Unchanged) | View |
| 2022-01-13 08:30 am Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Kamin Peter | 781,956 18.6% | 0 (Unchanged) | View |
| 2021-12-06 4:32 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Kamin Peter | 781,956 18.7% | 0 (Unchanged) | View |
| 2021-11-12 5:21 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | 1315 Capital II L.P. | 3,166,666 26.4% | 0 (Unchanged) | View |
| 2021-11-12 4:31 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Ampersand 2018 Limited Partnership | 4,666,666 38.9% | 0 (Unchanged) | View |
| 2021-05-19 5:39 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | 1315 Capital II L.P. | 3,166,666 26.5% | 0 (Unchanged) | View |
| 2021-05-18 5:01 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Ampersand 2018 Limited Partnership | 4,666,666 39.1% | 0 (Unchanged) | View |
| 2021-03-01 4:06 pm Purchase | 13D | INTERPACE BIOSCIENCES INC IDXG | Kamin Peter | 781,956 19.3% | 781,956 (New Position) | View |
| 2021-02-12 5:06 pm Sale | 13G | INTERPACE BIOSCIENCES INC IDXG | Stonepine Capital Management LLC | 0 0% | -277,277 (Position Closed) | View |
| 2021-01-21 4:49 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | 1315 Capital II L.P. | 3,166,666 26.6% | 0 (Unchanged) | View |
| 2021-01-19 4:13 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Ampersand 2018 Limited Partnership | 4,666,666 39.3% | 0 (Unchanged) | View |
| 2020-09-11 4:34 pm Purchase | 13G | INTERPACE BIOSCIENCES INC IDXG | Stonepine Capital Management LLC | 277,277 6.9% | 169,517 (+157.31%) | View |
| 2020-08-20 3:57 pm Sale | 13D | INTERPACE BIOSCIENCES INC IDXG | Binsalamah Ziyad | 0 0% | -300,000 (Position Closed) | View |
| 2020-07-24 09:10 am Purchase | 13D | INTERPACE BIOSCIENCES INC IDXG | Binsalamah Ziyad | 300,000 7.43% | 300,000 (New Position) | View |
| 2020-04-30 08:15 am Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | 1315 Capital II L.P. | 3,166,666 26.7% | 0 (Unchanged) | View |
| 2020-04-22 5:40 pm Unchanged | 13D | INTERPACE BIOSCIENCES INC IDXG | Ampersand 2018 Limited Partnership | 4,666,666 39.3% | 0 (Unchanged) | View |
| 2020-04-17 4:36 pm Purchase | 13G | INTERPACE BIOSCIENCES INC IDXG | Stonepine Capital Management LLC | 107,760 2.7% | 107,760 (New Position) | View |